Susceptibility Pattern and Molecular Type of Species-specific Candida in Oropharyngeal Lesions of Indian Human Immunodeficiency Virus-positive Patients

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2004 Mar 9

PMID 15004088

Citations 14

Authors

Ali Abdul Lattif

Uma Banerjee

Rajendra Prasad

Ashutosh Biswas

Naveet Wig

Neeraj Sharma

Absarul Haque

Nivedita Gupta

Najma Z Baquer

Gauranga Mukhopadhyay

Affiliations

Soon will be listed here.

Abstract

A study of oropharyngeal candidiasis (OPC) in Indian human immunodeficiency virus (HIV)/AIDS patients was conducted over a period of 15 months. This study revealed that 75% of the HIV/AIDS patients had OPC. MIC testing revealed that 5% of the Candida isolates were fluconazole resistant. A correlation between CD4(+)-T-cell counts and development of OPC in HIV/AIDS patients was also observed. Molecular typing of C. albicans isolates showed that all were genetically unrelated.

Citing Articles

Epidemiology and Prevalence of Oral Candidiasis in HIV Patients From Chad in the Post-HAART Era.

Taverne-Ghadwal L, Kuhns M, Buhl T, Schulze M, Mbaitolum W, Kersch L Front Microbiol. 2022; 13:844069.

PMID: 35250957 PMC: 8891798. DOI: 10.3389/fmicb.2022.844069.

Association of oral candidal species with human immunodeficiency virus patients of West Godavari district, Andhra Pradesh - An study.

Mounika R, Nalabolu G, Pallavi N, Birajdar S J Oral Maxillofac Pathol. 2021; 25(1):147-153.

PMID: 34349426 PMC: 8272515. DOI: 10.4103/jomfp.jomfp_504_20.

Oral candidiasis in HIV-uninfected pediatric population in areas with limited fungal diagnosis: A case study from a tertiary hospital, Tanzania.

Mushi M, Loi N, Mshana S Ther Adv Infect Dis. 2021; 8:20499361211016964.

PMID: 34094534 PMC: 8141982. DOI: 10.1177/20499361211016964.

Antifungal Resistance of Species Isolated from HIV Patients in a Tertiary Care Hospital, Mysuru, Karnataka.

Shivaswamy U, Sumana M Indian J Dermatol. 2020; 65(5):423-425.

PMID: 33165341 PMC: 7640784. DOI: 10.4103/ijd.IJD_385_19.

Biofilm-Producing Species Causing Oropharyngeal Candidiasis in HIV Patients Attending Sukraraj Tropical and Infectious Diseases Hospital in Kathmandu, Nepal.

Lamichhane K, Adhikari N, Bastola A, Devkota L, Bhandari P, Dhungel B HIV AIDS (Auckl). 2020; 12:211-220.

PMID: 32606995 PMC: 7304782. DOI: 10.2147/HIV.S255698.

References

Lischewski A, Harmsen D, Wilms K, Baier G, Gunzer U, Klinker H . Molecular epidemiology of Candida albicans isolates from AIDS and cancer patients using a novel standardized CARE-2 DNA fingerprinting technique. Mycoses. 1999; 42(5-6):371-83. DOI: 10.1046/j.1439-0507.1999.00474.x. View

Jabra-Rizk M, Baqui A, Kelley J, Falkler Jr W, Merz W, Meiller T . Identification of Candida dubliniensis in a prospective study of patients in the United States. J Clin Microbiol. 1999; 37(2):321-6. PMC: 84296. DOI: 10.1128/JCM.37.2.321-326.1999. View

Meiller T, Jabra-Rizk M, Baqui A, Kelley J, Meeks V, Merz W . Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 88(5):573-80. DOI: 10.1016/s1079-2104(99)70088-0. View

Soll D . The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev. 2001; 13(2):332-70. PMC: 100156. DOI: 10.1128/CMR.13.2.332. View

Rex J, Walsh T, Sobel J, Filler S, Pappas P, Dismukes W . Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis. 2000; 30(4):662-78. DOI: 10.1086/313749. View

Jabra-Rizk M, Falkler Jr W, Merz W, Baqui A, Kelley J, Meiller T . Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals. J Clin Microbiol. 2000; 38(6):2423-6. PMC: 86831. DOI: 10.1128/JCM.38.6.2423-2426.2000. View

SLIFKIN M . Tween 80 opacity test responses of various Candida species. J Clin Microbiol. 2000; 38(12):4626-8. PMC: 87648. DOI: 10.1128/JCM.38.12.4626-4628.2000. View

Brambilla A, Castagna A, Nocita B, Hasson H, Boeri E, Veglia F . Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections. J Acquir Immune Defic Syndr. 2001; 27(1):44-8. DOI: 10.1097/00126334-200105010-00008. View

Perea S, Lopez-Ribot J, Kirkpatrick W, McAtee R, Santillan R, Martinez M . Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2001; 45(10):2676-84. PMC: 90716. DOI: 10.1128/AAC.45.10.2676-2684.2001. View

10.

Vazquez J . Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients. HIV Clin Trials. 2001; 1(1):47-59. DOI: 10.1310/T7A7-1E63-2KA0-JKWD. View

11.

Jabra-Rizk M, Ferreira S, Sabet M, Falkler W, Merz W, Meiller T . Recovery of Candida dubliniensis and other yeasts from human immunodeficiency virus-associated periodontal lesions. J Clin Microbiol. 2001; 39(12):4520-2. PMC: 88577. DOI: 10.1128/JCM.39.12.4520-4522.2001. View

12.

Vargas K, Joly S . Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals. J Clin Microbiol. 2002; 40(2):341-50. PMC: 153371. DOI: 10.1128/JCM.40.2.341-350.2002. View

13.

Harry J, Song J, Lyons C, White T . Transcription initiation of genes associated with azole resistance in Candida albicans. Med Mycol. 2002; 40(1):73-81. DOI: 10.1080/mmy.40.1.73.81. View

14.

Fidel Jr P . Immunity to Candida. Oral Dis. 2002; 8 Suppl 2:69-75. DOI: 10.1034/j.1601-0825.2002.00015.x. View

15.

Martinez M, Lopez-Ribot J, Kirkpatrick W, Coco B, Bachmann S, Patterson T . Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole. J Clin Microbiol. 2002; 40(9):3135-9. PMC: 130753. DOI: 10.1128/JCM.40.9.3135-3139.2002. View

16.

Fidel Jr P . Distinct protective host defenses against oral and vaginal candidiasis. Med Mycol. 2002; 40(4):359-75. View

17.

Myers T, Leigh J, Arribas A, Hager S, Clark R, Lilly E . Immunohistochemical evaluation of T cells in oral lesions from human immunodeficiency virus-positive persons with oropharyngeal candidiasis. Infect Immun. 2003; 71(2):956-63. PMC: 145388. DOI: 10.1128/IAI.71.2.956-963.2003. View

18.

Vazquez J . Invasive oesophageal candidiasis: current and developing treatment options. Drugs. 2003; 63(10):971-89. DOI: 10.2165/00003495-200363100-00004. View

19.

Makarova N, Pokrowsky V, Kravchenko A, Serebrovskaya L, James M, McNeil M . Persistence of oropharyngeal Candida albicans strains with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long-term care facility. J Clin Microbiol. 2003; 41(5):1833-7. PMC: 154751. DOI: 10.1128/JCM.41.5.1833-1837.2003. View

20.

Schmid J, Voss E, Soll D . Computer-assisted methods for assessing strain relatedness in Candida albicans by fingerprinting with the moderately repetitive sequence Ca3. J Clin Microbiol. 1990; 28(6):1236-43. PMC: 267911. DOI: 10.1128/jcm.28.6.1236-1243.1990. View